Document is current
Any future updates will be listed below
-
Authors
Linnér, Erik https://orcid.org/0009-0004-6961-8957
Czuba, Tomasz
Gidlöf, Olof https://orcid.org/0000-0002-7402-3139
Lundgren, Jakob https://orcid.org/0000-0001-9338-2906
Bollano, Entela https://orcid.org/0000-0003-3341-2434
Hellberg, Maria
Celik, Selvi https://orcid.org/0000-0001-7032-3444
Pimpalwar, Neha
Rentzsch, Philipp https://orcid.org/0000-0002-0413-7974
Martorella, Molly https://orcid.org/0000-0002-3306-6650
Gummesson, Anders https://orcid.org/0000-0003-0024-960X
Melander, Olle https://orcid.org/0000-0002-2581-484X
Albinsson, Sebastian https://orcid.org/0000-0001-6936-3967
Dellgren, Göran https://orcid.org/0000-0003-4961-9704
Borén, Jan https://orcid.org/0000-0003-0786-8091
Jeppsson, Anders https://orcid.org/0000-0003-2356-2295
Lumbers, R. Thomas https://orcid.org/0000-0002-9077-4741
Shah, Sonia https://orcid.org/0000-0001-5860-4526
Nilsson, Johan https://orcid.org/0000-0001-6860-6090
Natarajan, Pradeep https://orcid.org/0000-0001-8402-7435
Lappalainen, Tuuli https://orcid.org/0000-0002-7746-8109
Levin, Malin https://orcid.org/0000-0003-1069-5275
Ehrencrona, Hans https://orcid.org/0000-0002-5589-3622
Smith, J. Gustav https://orcid.org/0000-0001-6285-9935
-
Funding
Funding for this research was provided by:
Lund University
- License Information
-
More Information
Article History
Received: 4 October 2024
Accepted: 28 January 2025
First Online: 5 February 2025
Declarations
:
: R.T.L reports research grants from Pfizer and consultancy fees from FITFILE and HealthLumen, unrelated to the present work. P.N. reports research grants from Allelica, Amgen, Apple, Boston Scientific, Genentech / Roche, and Novartis, personal fees from Allelica, Apple, AstraZeneca, Blackstone Life Sciences, Creative Education Concepts, CRISPR Therapeutics, Eli Lilly & Co, Foresite Labs, Genentech / Roche, GV, HeartFlow, Magnet Biomedicine, Merck, and Novartis, scientific advisory board membership of Esperion Therapeutics, Preciseli, and TenSixteen Bio, scientific co-founder of TenSixteen Bio, equity in MyOme, Preciseli, and TenSixteen Bio, and spousal employment at Vertex Pharmaceuticals, all unrelated to the present work. Other authors have no conflicts to declare.
